Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,469
Closed -$121K 3808
2024
Q2
$121K Buy
+12,469
New +$123K ﹤0.01% 3724
2022
Q2
Sell
-1,562
Closed -$28K 4080
2022
Q1
$28K Sell
1,562
-7,617
-83% -$237K ﹤0.01% 3969
2021
Q4
$521K Buy
9,179
+2,232
+32% +$149K ﹤0.01% 3373
2021
Q3
$524K Buy
6,947
+3,333
+92% +$353K ﹤0.01% 3406
2021
Q2
$607K Buy
3,614
+69
+2% +$12.1K ﹤0.01% 3332
2021
Q1
$622K Buy
3,545
+1,115
+46% +$225K ﹤0.01% 3253
2020
Q4
$498K Buy
2,430
+750
+45% +$139K ﹤0.01% 3207
2020
Q3
$328K Buy
+1,680
New +$405K ﹤0.01% 3284

Other funds holding GOCO

Invesco's GOCO Position: Q3 2024 in Review

Invesco sold out of GoHealth (GOCO) in Q3 2024, closing a stake of 12,469 shares — an estimated $121K sold.

Invesco first reported a position in GOCO in Q3 2020 and held it in 8 quarters. The position peaked at $622K in Q1 2021. 46 funds tracked by Wall St. Rank hold GOCO as of Q3 2024.

  • Invesco reported no remaining GoHealth position as of Q3 2024 after selling out during the quarter.
  • Invesco sold 12,469 GoHealth shares in Q3 2024, an estimated $121K.
  • Invesco first reported a position in GoHealth in Q3 2020 and held it in 8 quarters.
  • Invesco's GoHealth position peaked at $622K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held GoHealth as of Q3 2024.

Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.